Bupivacaine - Cellix Bio
Alternative Names: Bupivacaine PO6FA; CLX-117; CLX-ONC-17; LBS-101-1Latest Information Update: 28 Mar 2022
Price :
$50 *
At a glance
- Originator Cellix Bio
- Developer Cellix Bio; RVL
- Class Analgesics; Anilides; Anti-inflammatories; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Piperidines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mucositis
- Discontinued Postoperative pain